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Background: The impact of influenza on young children can be severe and even fatal. Influenza vaccination (IV)
has been shown to be effective in reducing complications of influenza among children. This study investigated the
prevalence and factors of IV among children aged 6-23 months in Hong Kong.
Methods: A sample of 401 Chinese parents of children aged 6-23 months were interviewed at local Maternal and
Child Health Centers. Socio-demographic information, variables related to Health Belief Model, including perceptions
about the child’s chance of contracting influenza, perceived harm of influenza on children, perceived benefits and
side-effects of IV, having received recommendations from health professionals to uptake IV, and IV behaviors of the
children were measured. Multivariate analysis was used to examine factors associated with IV behaviors of children.
Results: Only 9% of the children had ever been vaccinated. Among those parents who had heard of IV (92.0%),
substantial proportions perceived that IV could reduce the risk of influenza-induced complications (70.5%),
hospitalization (70.5%) and death (65.9%). Relatively few of the participants believed that IV had no side effects
(17.1%) and even less had been recommended by health care professionals to uptake IV (10.6%). Results from multi-
variate analysis showed that physician recommendations were associated with a higher likelihood for IV among
younger children, whilst parental perceptions of the side effects of IV was associated with a lower likelihood for IV.
Conclusion: The prevalence of IV among children aged 6-23 months in Hong Kong was very low. Promotion of IV with
the component of physician recommendations and parents’ knowledge about IV safety for this group is warranted.
Keywords: Influenza vaccination, Parental perceptions, Children, Health belief model, ChineseBackground
The impact of influenza on young children can be severe
and even fatal [1,2]. Although fatal cases from influenza
infection among pediatric patients are rare, the preva-
lence of complications leading to hospitalization is quite
high [3-5]. In Hong Kong, the adjusted rates of excess
hospitalization for acute respiratory disease attributable
to influenza were estimated to be 278.5 and 288.2 per
10,000 for children less than 1 year of age and 218.4 and* Correspondence: jlau@cuhk.edu.hk
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reproduction in any medium, provided the or209.3 per 10,000 for children 1 to less than 2 years of
age in 1998 and 1999, respectively [6]. Many influenza-
associated hospitalizations could be avoided.
Influenza vaccination (IV) has shown to be effective in
reducing influenza-related complications in different age
groups [7-10], including pediatric patients [11]. Since
1994, the Hong Kong government has recommended eld-
erly persons living in residential care homes, health care
workers, poultry workers, persons aged 65 years or above,
persons with a chronic illness, and children aged 6 to
23 months to take up IV [12,13]. The recommendation
was later extended to children aged 6 to 59 months in
2010 [14] and adults aged 50 years old or above in 2012
[15]. Similar recommendations are found in other coun-
tries such as North America [16-19] and are also provided. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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World Health Organization (WHO) [20].
Furthermore, since 2005 the Hong Kong government
has provided free IV to children aged 6 to 23 months
old of families receiving the Comprehensive Social Se-
curity Assistance (CSSA) [21]; it was further extended to
children of age 6 to 59 months in 2010 [22]. In addition,
since 2008, the government has launched the Childhood
Influenza Vaccination Subsidy Scheme (CIVSS) to
subsidize all children aged 6-59 months old to take up
IV from private practitioners. The subsidy was increased
from HK$80 (US$10) to HK$130 (US$16.5) per dose
since September 24, 2012 [23], whilst the market rate for
IV was about HK$150-200 (US$19.2 to US$25.6).
Despite the recommendations and supportive policy,
the prevalence of IV in different populations is low in
Hong Kong. Population-based studies, in 2005, showed
that 75.7% of respondents aged 18 to 64 in Hong Kong
had never received an IV [24]. To our knowledge, there
is no data on the prevalence of IV uptake among chil-
dren aged 6 to 23 months old in Hong Kong. A number
of western studies reported poor public awareness and
misconceptions about infectivity and severity of influ-
enza, as well as concerns over the safety of IV [25-28].
Studies showed that parental worry was an important
intervening variable affecting uptake of and compliance
with IV [29,30]. Similarly, studies have reported much
worry among parents with respect to their children’s risk
for contracting SARS and avian flu [31-33]. Therefore,
investigation of parental perceptions on IV is required
for understanding vaccination coverage among children.
A number of western studies examined factors associated
with IV among elderly [34-37] and other populations, such
as adults with asthma [38] or healthcare workers [39], but
relatively few of these studies targeted young children
[40-42]. Similarly in Hong Kong, most of the studies on IV
focused on the elderly population [43-46]. Despite the high
influenza-related morbidity rate among young children, rela-
tively few studies investigated IV in the 6-23 month old age
group and most of these studies were conducted in the
United States [47]. As Hong Kong has a higher population
density and worse air pollution compared to the United
States, it is expected that the prevalence of IV and associated
factors among young children would be different. To our
knowledge, no similar studies have ever been conducted for
the 6 to 23 month old children in Chinese populations.
This study investigated the prevalence of IV, the preva-
lence of completing the follow-up IV within one month
after getting the first IV shot in one’s lifetime and the
prevalence of parental behavioral intention for having
the child take up IV in the coming 12 months. Among
those parents who had heard of IV, we investigated fac-
tors associated with IV (i.e. having ever taken up IV, hav-
ing taken up IV in 2005/2006 flu season, inclination tohave the child take up IV in the coming 12 months)
amongst the index child aged 6-23 months. The Health
Belief Model (HBM) has been commonly used to identify
potential determinants of IV [29,45,48-51]. In the present
study, parental perceptions, with respect to influenza and
IV for the index child aged 6-23 months, were gauged
based on some constructs of the HBM: perceived suscep-
tibility of influenza, perceived severity of influenza, per-
ceived benefits of IV, perceived barriers of IV, and cues
to action for IV. In addition, descriptions with respect to
health services seeking behaviors in the last episode of in-
fluenza, reasons for taking up or not taking up IV, occur-
rences of any side-effects for the last episode of IV, and
incompletion of the second dose were reported.
Methods
Study population and sampling
The study population comprised of the Chinese father or
mother of a child aged 6 to 23 months old, who utilized the
services in one of the ten randomly selected Maternal and
Child Health Centres (MCHCs) in Hong Kong (out of a
total of 31 MCHCs). The MCHCs in Hong Kong are public
health centers of the Department of Health offering health
services to mothers or children under the age of 11. All local
children of that age range can receive child health services
and pneumococcal vaccination MCHCs free of charge. In
2009, about 74% of all local newborns had received free ser-
vices from MCHCs [52]. The study was conducted during
May to June, 2006. Research assistants were trained as field-
workers for the study. Using convenience sampling
methods, either the father or the mother (but not both), was
invited to join the study while they were waiting to receive
services in the MCHCs during the research period. In the
waiting hall, prospective respondents were approached and
were briefed by these well-trained fieldworkers and were in-
vited to join the study. Trained fieldworkers interviewed the
eligible respondents in a private setting using an anonymous
structured questionnaire. The face-to-face interview took
about 15 minutes to complete. A total of 429 eligible pro-
spective respondents were approached and 401 consented
to take part. All of them completed the interview. The re-
sponse rate, defined as the number of completed interviews
divided by the number of eligible respondents being invited
to join the study, was hence 93.5%. Verbal informed consent
was obtained from the respondents before the interviews
commenced. The interviewers signed a form explaining the
details of the study to the respondents. Ethics approval was
obtained from both the ethics committees at the Chinese
University of Hong Kong and the Department of Health.
Measures
Respondents’ socio-demographic information such as gen-
der of the index child, age, education level, whether the
household was receiving CSSA, and residential district
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perceived susceptibility (i.e. chance of contracting influ-
enza by children aged 6 to 23 months old compared to
the general public) and perceived severity of influenza (i.e.
severity of influenza in the index child and in children
aged 6 to 23 months compared to the general public), per-
ceived benefits (i.e. reduction of influenza-induced compli-
cations, hospitalization and fatality) and perceived barriers
of IV (i.e. perceived side effects of IV), and cues to action
(i.e. ever receiving recommendations from healthcare pro-
fessionals to uptake IV and awareness of governmental
recommendations for children aged 6-23 months to take
up IV) were assessed by items that were constructed for
this study.
Information related to IV, such as whether the partici-
pants had ever heard of IV, whether the index child had
ever taken up IV and whether a follow-up second dose
at one month was received after taking up the first IV
shot in the child’s lifetime were recorded. Additional in-
formation documented included the inclination to have
the child take up IV in the coming 12 months as well as
conditions that would facilitate such a behavior in the
coming 12 months. Other information related to the last
episode of IV including the venue of vaccination, the
most important reason for the child having or not hav-
ing taken up IV, completing the 2-dose course at one
month after taking up the first IV in the child’s lifetime,
and side effects as well as the nature of the side effects,
if any, was reported. Health services seeking behaviors
with respect to the child’s last episode of influenza and
the maximum amount of money that the parent was
willing to pay for IV to reduce the child’s risk of con-
tracting IV was also recorded.
Statistical analysis
Descriptive statistics were presented. There were three
dependent variables: 1) having ever taken up IV; 2)
having taken up IV since the end of the last flu season
(September 2005); and 3) inclination to have the child
take up IV in the coming 12 months. The independent
variables included all the socio-demographic variables
(listed in Table 1), the HBM variables (listed in Table 2),
and willingness to pay variable (listed in Table 2). As
some potential factors related to perceptions of IV, only
those respondents who reported having had heard of IV
were included in the logistic regression analyses. To
identify factors associated with the dependent variables,
univariate logistic regression analyses were performed
first and resulting univariate odds ratios (ORu) were pre-
sented. We then used those factors that were significant
in the univariate analyses as candidates for multivariate
stepwise logistic regression analyses to derive multivari-
ate odds ratios (ORm) and respective 95% confidence in-
tervals (CI); a set of significant independent variableswas hence selected by that model. All statistical analyses
were performed using SPSS for Windows 14.0 and a p-
value of < 0.05 was taken as statistically significant.
Results
Background characteristics
Of all respondents, 84.8% were mothers, 81.0% were aged
25 to 39; 27.7% had attained an education level of post-
secondary school or above; 2.5% were receiving CSSA
(Table 1). Of the index children, 45.0% were female.
Perceived susceptibility and severity of influenza
Of all respondents, 50.8% perceived very severe or severe
health impacts on the index child if the child was to
contract influenza; 61.6% perceived influenza to have
more severe or much more severe health consequences
on children aged 6 to 23 months old than on the general
public; 57.6% perceived children aged 6 to 23 months old
to have higher or much higher chances of contracting in-
fluenza as compared to the general public (Table 1).
Prevalence and perceptions related to IV
Of all the respondents, 92.0% had heard of IV. However,
only 9.0% of all index children had ever taken up IV, and
8.5% of all index children had done so during the 2005/06
flu season (Table 1). Of all the respondents, a total of 151
planned to have their index child receive IV in the coming
12 months (40.9% for parents who had heard of IV).
Of those who had heard of IV (92% of all respon-
dents), similar proportions perceived that IV could re-
duce the risk of influenza-induced complications (70.5%)
and hospitalization (70.5%); 65.9% perceived that IV
could reduce the risk of death due to influenza; 88.1%
believed that IV could reduce at least one of the three
types of complications (perceived benefit). However, sig-
nificant proportions of the respondents chose the “don’t
know” answer (13.6% to 16.3%) for such questions. It is
important to point out that only a minority of the re-
spondents (17.1%) perceived that IV had no side effects
on children aged 6 to 23 months old (perceived barrier).
With respect to cues to action, only 10.6% of the respon-
dents had been recommended by some health care pro-
fessionals to vaccinate their child whereas 68.8% of them
were not aware of the governmental recommendations re-
garding the uptake of IV in children aged 6 to 23 months
old. More than a quarter (27.9%) of the respondents were
willing to pay over HK$300 (approx. US$38.68), while
44.2% were willing to pay HK$1-150 (approx. US$0.13-
19.34) to obtain some benefits (such as reduction of the
risk of influenza-induced complications/hospitalization)
from their index child being vaccinated (Table 2).
Concerning descriptions on facilitating conditions, sub-
stantial proportions of the respondents believed that
recommendations provided by health care professionals
Table 1 Background characteristics of all







18 – 19 2 0.5
20 – 24 24 6.0
25 – 29 74 18.5
30 – 34 159 39.7
35 - 39 92 22.9
40 – 44 44 11.0
45 – 49 4 1.0
50 – 54 2 0.5
Education level
Primary school or below 19 4.7
Junior – senior secondary school 271 67.6
Post secondary or matriculation 32 8.0




Refused to answer 6 1.5
Gender of the index children
Male 221 55.1
Female 180 44.9
Age of the index children
6 months to 12 months 194 48.9
13 months to 23 months 203 51.1
Information related to influenza
Perceived health impact on own child if
contracting influenza (perceived severity)
Very severe/Severe 204 50.8
Moderate 157 39.2
Mild 16 4.0
No effect 7 1.7
Do not know 17 4.2
Perceived consequences of contracting
influenza in children aged 6-23 months
compared to the general public (perceived severity)
Much more severe/More severe 247 61.6
Same 128 31.9
Less severe/Much less severe 21 5.4
Do not know 4 1.0
Table 1 Background characteristics of all
respondents (N = 401) (Continued)
Perceived chances for children aged 6-23
months to contract influenza compared to
the general public (perceived susceptibility)
Much higher/Higher 231 57.6
Same 122 30.4
Lower/Much lower 47 11.7
Do not know 1 0.2
Ever heard of IV 369 92.0
Ever had IV 36 9.0
Received IV in the 05/06 flu season 34 8.5
Age of the index children at the last IVa
6 months to 12 months 16 47.1
13 months to 21 months 18 52.9
Health service seeking behaviors for
the last influenzab




Took herbal medicine 10 2.5
Visited acute and emergency unit 8 2.0
Took over-the-counter western medicine 6 1.5
Saw a traditional Chinese
medicine (TCM) doctor
2 0.5
Took over-the-counter TCM 1 0.2
No treatment/No drugs used 5 1.2
Do not know 1 0.2
Not ever having influenza 99 24.3
#Valid percentages were reported (i.e. missing values were not included in the
denominator) and the frequencies therefore may not sum up to the total.
aAmong those who had received IV in the 05/06 flu section (N = 34).
bAmong those who had had influenza (N = 302). Multiple answers were
allowed, so summing up the individual numbers (n) might not be equal to the
total number of respondents (N) in each sample.
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(72.6%), the reporting of a new human case of avian flu in
Hong Kong (65.3%) and proximity to a venue providing
IV services (64.8%) would increase the index child’s likeli-
hood for taking up IV (Table 1).
Facts related to the last episode of IV
Among those index children who had received IV during
the 2005/06 flu season (N = 34), 64.7% took up the IV in
private clinics, 11.8% in MCHCs and 2.9% in govern-
mental clinics. The most important reasons mentioned
to account for this episode of IV included: “influenza
prevention” (47.1%), “worry about the child contracting
influenza/avian influenza” (32.3%), “being recommended
by health care professionals” (14.7%), and “influenced by
peer/family” (2.9%). Five (15%) respondents reported their
index child had had some side effects associated with his/
Table 2 Perceptions related to influenza and influenza
vaccination (IV) and facilitating conditions related to IV
among parents of young children who had heard of
IV (N = 369)
n %#
Perceptions related to influenza and IV
Perceived chances for children aged 6-23
months to contract influenza compared to
the general public (perceived susceptibility)
Much higher/Higher 213 57.8
Same 112 30.3
Lower/Much lower 44 11.9
Perceived health impact on own child if
contracting influenza (perceived severity)
Very severe/Severe 193 52.3
Moderate 142 38.5
Mild 15 4.1
No effect 6 1.6
Do not know 13 3.5
Perceived consequences of contracting
influenza in children aged 6-23 months
compared to the general public (perceived severity)
Much more severe/More severe 212 57.8
Same 111 30.2
Less severe/Much less severe 44 12.0





Do not know 60 16.3
Perceived benefit of IV in reducing risk of
hospitalization due to influenza (perceived benefit)
Yes 260 70.5
No 49 13.3
Do not know 60 16.3
Perceived benefit of IV in reducing risk of
death due to influenza (perceived benefit)
Yes 243 65.9
No 76 20.6
Do not know 50 13.6
Perceived benefit of IV in reducing at least




Perceived side effects of IV (perceived barrier)
No side effect 63 17.1
Not severe 167 45.3
Severe 13 3.5
Do not know 126 34.1
Table 2 Perceptions related to influenza and influenza
vaccination (IV) and facilitating conditions related to IV
among parents of young children who had heard of
IV (N = 369) (Continued)
Had ever received recommendations from
healthcare professionals to uptake IV (cue to action)
Yes 39 10.6
No 329 89.4
Awareness of governmental recommendation on
children aged 6-23 months to take up IV (cue to action)
Yes 115 31.2
No 152 41.2
Do not know 102 27.6
Inclined to have the child taking up IV
in the coming 12 months
Yes 151 40.9
No 116 31.4
Do not know 102 27.6
The largest amount willing to pay for IV which
could effectively reduce the risk of influenza-induced
complications/hospitalization (in HK$)a
0 36 9.8
1 – 150 127 34.4
151 – 300 103 27.9
301 – 500 61 16.5
501 – 1000 22 6.0
> 1000 20 5.4
Facilitating conditions of IV
More likely to be vaccinated if IV is to be
provided proximal to residence
Yes 239 64.8
No 103 27.9
Do not know 27 7.3
More likely to be vaccinated if supported by family
Yes 268 72.6
No 77 20.9
Do not know 24 6.5
More likely to be vaccinated if recommended
by health care professionals
Yes 333 90.2
No 23 6.2
Do not know 13 3.5
More likely to be vaccinated if there is a new
human case of avian flu in Hong Kong
Yes 241 65.3
No 96 26.0
Do not know 32 8.7
#Valid percentages were reported (i.e. missing values were not included in the
denominator) and the frequencies therefore may not sum up to the total.
aHK$1 = US$ 0.13.
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was the only side effect that was being mentioned (N = 4)
(Table 3).
“Not necessary” (23.2%), “do not know/had not thought
about it” (11.4%), “the child is in good health condition”
(10.7%), “the baby is too young” (10.0%), “had not been
recommended by health care professionals” (8.8%) and
“worry about side effects of IV” (8.1%) were the most com-
monly given reasons to explain why the index child had
never taken up IV or did not take up IV during the 2005/
06 flu season. Other reasons were presented in Table 3.
Compliance with the recommendations for 2 doses of
influenza vaccine in the index children first vaccinated
Among a total of 36 children having previously been
vaccinated, 12 (33.3%) had only taken up one shot of IV
in their lifetime (i.e., without taking up the required sec-
ond dose, which should be within an one month interval).
The most important reasons for not completing the 2-
dose course of IV included: “did not realize that a follow-
up dose was required” (n = 4), “out of stock” (n = 2), “the
child was sick” (n = 2), and other reasons (n = 4). All the
remaining 24 children (66.7%) had received the follow-up
IV after receiving the first lifetime IV shot (Table 4).
Factors associated with adoption of IV
For all three dependent variables, none of the background
variables listed in Table 1 were found to be statistically sig-
nificant in the univariate analyses. As mentioned in the
section in Statistical Analysis, these variables were hence
not considered in the subsequent multivariate analyses.
The results of the multivariate analyses showed that
variables for cues to action, including recommendations
provided by health care professionals that the index child
should take up IV (multivariate OR = 17.65, p < 0.01) and
awareness of the governmental recommendation that chil-
dren aged 6 to 23 months old should take up IV (multi-
variate OR = 2.81, p < 0.05) were associated with the index
child getting the IV sometime during their lifetime. Lower
likelihood for ever taking up IV was found for variables on
perceived side effects induced by IV (multivariate OR =
0.17, p < 0.01) and uncertainty about whether IV has some
side effects (multivariate OR = 0.06, p < 0.01) (Table 5).
Similar multivariate analysis showed that recommen-
dations provided by health care professionals, that the
index child should take up IV, (multivariate OR = 17.28,
p < 0.01) were associated with the index child’s experi-
ence when they received the IV during the 2005/06 flu
season. Similarly, the reverse was true that perceived IV-
induced side effects (multivariate OR = 0.16, p < 0.01)
and uncertainty about the presence of such side effects
(multivariate OR = 0.06, p < 0.01) were associated with
lower likelihood of vaccination during the 2005/06 flu
season. Awareness of the government’s recommendationthat children aged 6 to 23 months should take up IV
was significant in the univariate but not in the multivari-
ate analysis (Table 5).
Furthermore, the perceived benefit of IV in reducing the
risk of influenza-induced complications, hospitalization or
death (multivariate OR = 3.20, p < 0.05), perceived severity
of a potentially severe/very severe negative health impact
of influenza onto the index children (multivariate OR =
2.69, p < 0.05), and cue to action represented by recom-
mendations provided by health care professionals that
the index child should take up IV (multivariate OR = 2.31,
p < 0.05) were associated with parental inclination towards
having their index children take up IV in the coming
12 months. Significant associations in the opposite direc-
tion were found for variables including perceived side
effects of IV (multivariate OR = 0.51, p < 0.05) and uncer-
tainty about the presence of such side effects (multivariate
OR = 0.37, p < 0.01). Willingness to pay for the benefits of
IV in reducing risk for influenza-induced complications/
hospitalization and awareness of the governmental recom-
mendation for children aged 6 to 23 months old were of
statistical significance in the univariate but not in the
multivariate analysis (Table 5).Health service seeking behaviors for the index Child’s last
episode of influenza
The model health service seeking behaviors during the
index child’s last episode of influenza was visiting private
doctors (57.2%), followed by visiting governmental clinics
(10.3%). Other much less frequently mentioned options
included using herbal medicine (2.5%), visiting Acute and
Emergency Unit (2.0%), using over-the-counter western
medicine (1.5%), seeing a traditional Chinese medicine
(TCM) doctor (0.5%), and using over-the-counter TCM
(0.2%). Only a few of all the respondents refused to seek
any treatment, or use any drugs (1.2%) during that last
episode of influenza suffered by the index child (Table 1).Discussion
We found that only 9% of the children aged 6 to
23 months old had ever received IV (8.5% in the 2005/06
flu season). This prevalence is far lower than the 32.2%
prevalence of IV reported for the same age group in the
United States in 2005 [39]. Among the children who have
ever received IV, the majority of them received the IV in
the 2005/06 season. Since about half of the children were
below the age of 12 months at the survey date, it is con-
ceivable that they could only receive IV in the current sea-
son. We also found that about two thirds of the parents
were not aware of the governmental recommendation re-
garding IV for children aged 6 to 23 months and 8% of
them had not even heard of IV. Therefore, promotion of
IV targeting parents of this age group is urgently needed.
Table 3 Information related to influenza vaccination (IV)
since September 2005 (i.e., in the 05/06 flu season)
n %#
Place where the last episode of IV was receiveda
Private clinics 22 64.7
Maternal and Child Health Centres 4 11.8
School 3 8.8
Outside Hong Kong 3 8.8
Home 1 2.9
Government/HA general outpatient clinics 1 2.9
The most important reason of IV uptake
(last episode)a
Prevent influenza 16 47.1
Worried about contracting influenza/avian influenza 11 32.3
Recommended by health care professional 5 14.7
Influence by peer/family 1 2.9
Others 1 2.9
Self-reported side effects (last episode of IV)a
Yes 5 14.7
No 29 85.3
Perceived types of side effect, if any
(last episode of IV)a b
Fever 4 80.0
Cannot remember/do not know 1 20.0
The most important reason of not uptaking IVc
Not necessary 98 23.2
Do not know/had not thought about it 48 11.4
Good health conditions 45 10.7
Baby is too young 42 10
Had not been recommended by health
care professional
37 8.8
Worried about side effects of IV 34 8.1
Out of stock 18 4.3
Afraid of clashing with other injections 15 3.6
Perceived that IV was not efficacious 13 3.1
Seldom go out 11 2.6
Did not know where to get IV 10 2.4
Sick 8 1.9
Not living in Hong Kong 5 1.2
Busy 4 0.9
Fear of too many injections required 4 0.9
Did not want to uptake IV 3 0.7
Perceived that the IV taken more than
6 months ago was still efficacioius
3 0.7
Cannot afford it 3 0.7
Table 3 Information related to influenza vaccination (IV)
since September 2005 (i.e., in the 05/06 flu season)
(Continued)
Allergic to IV 3 0.7
Inadequate knowledge about IV 3 0.7
No reason given 2 0.5
Others (e.g., need to inject twice, etc.) 13 3
#Valid percentages were reported (i.e. missing values were not included in the
denominator) and the frequencies therefore may not sum up to the total.
aAmong children aged 6-23 months who had taken up IV since September
2005 (N = 34).
bMultiple answers were allowed, so summing up the individual numbers (n)
might not be equal to the total number of respondents (N) in each sample.
cAmong children aged 6-23 months who had not yet taken IV or not uptake IV
since September 2005 (N = 335).
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cinated, the most common reasons mentioned were that
parents believed it to be “unnecessary”, “the child is in
good health condition” and “the baby is too young”. This
is consistent with other study findings that there is a
lack of parental awareness about the importance of IV
among healthy young children, children with chronic
health conditions, and children in close contact with
high-risk individuals [42,53-55]. In addition, a significant
proportion of the parents gave “don’t know” answers to
IV related knowledge. Together, these results suggest a
need to increase parental education about influenza dis-
ease and IV. Multiple communication strategies includingTable 4 Prevalence of fully vaccinated with influenza
vaccine (IV) among children aged 6-23 months who ever
had received IV (N = 36)
n %#
The last episode of IV was:
a). The first shot in life
No follow-on second dose received 12a 33.3
Follow-on second dose received 0 0
b). Not the first shot in life
Being the second dose 24b 66.7
Not being the second dose 0 0
The most important reason for not having
the second dose of IVc
Did not realize a second dose of IV
was required
4 33.3
Out of stock 2 16.7
Sick 2 16.7
Others 4 33.3
#Valid percentages were reported (i.e. missing values were not included in the
denominator) and the frequencies therefore may not sum up to the total.
aAll 12 children received the last IV in the 2005/06 flu season except one.
bAll 24 children received the last IV in the 2005/06 flu season except one.
cAmong those who received the first IV shot in life but not the follow-on
second dose (N = 12).
Table 5 Predictors of influenza vaccination (IV) behaviors among parents of children aged 6 to 23 months who had heard of IV (N = 369)
Ever had influenza vaccination Vaccinated since September 2005 Inclined to be vaccinated in the next year
Row%# ORu ORm (95% CI) Row%
# ORu ORm (95% CI) Row%
# ORu ORm (95% CI)
Perceived chances for children aged 6-23 months to contract influenza as compared to the general public (perceived susceptibility)
Much lower/lower/same 7.7 1.00 7.7 1.00 38.7 1.00
Higher/much higher 11.2 1.51 NA 10.3 1.37 NA 42.5 1.17 NA
Perceived health impact on own child if contracting influenza (perceived severity)
No effect/mild 2.9 1.00 2.9 1.00 26.5 1.00 1.00
Moderate 7.0 2.50 7.0 2.50 26.1 0.98 0.75 (0.30 – 1.85)
Severe/very severe 13.0 4.91 NA 11.9 4.46 NA 54.4 3.31** 2.69 (1.13 – 6.42)*
Perceived consequences of contracting influenza in children aged 6-23 months compared to the general
public (perceived severity)
Much less severe/less severe/same 8.0 1.00 8.0 1.00 35.0 1.00
Much more severe/much severe 10.8 1.38 NA 9.9 1.26 NA 44.4 1.48 NA
Perceived benefits of IV in reducing at least risk of influenza-induced complications, hospitalization or
death (perceived benefits)
Else 6.8 1.00 6.8 1.00 15.9 1.00 1.00
Yes 10.2 1.55 NA 9.5 1.44 NA 44.3 4.21* 3.20 (1.29 – 7.93)*
Perceived side effects of IV (perceived barrier)
No 31.7 1.00 1.00 31.7 1.00 1.00 61.9 1.00 1.00
Yes 7.2 0.17** 0.17 (0.06 – 0.43)** 6.1 0.14** 0.16 (0.06 – 0.40)** 38.9 0.39** 0.51 (0.27 – 0.98)*
Do not know 2.4 0.05** 0.06 (0.01 – 0.24)** 2.4 0.05** 0.06 (0.02 – 0.25)** 33.3 0.31** 0.37 (0.18 – 0.74)**
Recommendation from healthcare professionals to uptake IV (cue to action)
No 4.5 1.00 1.00 4.5 1.00 1.00 37.9 1.00 1.00
Yes 53.8 24.50** 17.65 (7.10 – 43.89)** 48.7 19.95** 17.28 (6.97 – 42.83)** 66.7 3.28** 2.31 (1.04 – 5.12)*
Awareness of Government’s recommendation on children aged 6–23 months to uptake IV(cue to action)
No 6.6 1.00 1.00 6.6 1.00 37.5 1.00
Yes 19.1 3.36** 2.81 (1.03 – 7.67)* 17.4 2.99** 53.9 1.95**



















Table 5 Predictors of influenza vaccination (IV) behaviors among parents of children aged 6 to 23 months who had heard of IV (N = 369) (Continued)
The largest amount willing to pay for IV (HK$)a
0 2.8 1.00 2.8 1.00 16.7 1.00
1 – 150 11.0 4.34 11.0 4.34 36.2 2.84*
151 – 300 9.7 3.76 7.8 2.95 50.5 5.10**
>300 10.7 4.18 NA 10.7 4.18 NA 45.6 4.20** NS
#Valid percentages were reported (i.e. missing values were not included in the denominator) and the frequencies therefore may not sum up to the total.
*– p < 0.05; **– p < 0.01; ORu-- univariate odds ratio; ORm- multivariate odds ratio obtained from multivariate stepwise logistic regression; NA: not chosen for multivariate logistic regression analyses as the factor was
statistically non-significant in the univariate logistic regression analysis; NS: not statistically significant in the multivariate logistic regression. Variables that were significant in the p < 0.05 level were bolded.
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written information should be utilized [56-58].
In the logistic regression analyses, perceived benefits
of IV and perceived severity of influenza were associated
with a higher likelihood of IV, while perceived side ef-
fects of IV were associated with a lower likelihood of IV.
Such findings supported the predictability of the HBM
on IV in different age groups, including those of 6 to
23 months old [25,41]. Findings suggest that in addition
to increasing awareness and knowledge about IV, inter-
ventions are warranted to improve cognitions on IV
among parents of young children. The severity of influ-
enza and efficacy of IV in reducing influenza should be
highlighted. Misconceptions about side effects of IV in
young children should also be mitigated.
Corroborating with the results of other studies, a doc-
tor’s recommendation, which can be seen as a cue to ac-
tion, was an important factor associated with IV status
and inclinations [26,27,41,42,59,60]. However, only a mi-
nority of parents in this study had ever received recom-
mendations from a health care professional. There is
certainly a strong need to increase the awareness and
motivation of healthcare professionals in recommending
IV to parents of young children. As the majority of the
participants in the present study visited private clinics
during the last episode of IV, private doctors should be
mobilized to play a more important role in promoting
IV among young children of 6-23 months old or in other
age groups. Interventions should be designed to inform
the doctors about the evidence based benefits of IV to
relay to their patients and make doctors recognize the
strong influence they have on parental decision on hav-
ing their children vaccinated. However, there are some
potential barriers. In a study conducted in the U.S., only
50% of pediatricians and 40% of family physicians con-
sidered it is possible to give suggestions on regular IV
for children aged 6 through 35 months old; cost (77%),
vaccine safety issues (52%), and the inability to identify
eligible children (46%) were frequently cited as other im-
portant potential barriers for recommending IV to parents
of young children [61]. Future studies should address such
issues. Randomized clinical trials on different ways to em-
power physicians to give recommendations about IV to
parents of young children are greatly warranted.
It is also important to point out that 72.6% considered
family support as a facilitating condition for having the
child take up IV. Interventions should therefore be ex-
tended from parents and physicians to family members.
Family members are important people to parents of young
children. According to the Theory of Planned Behavior,
subjective norm is defined as support obtained from sig-
nificant others for performing a health-related behavior. It
is an important determinant of behavioral intention which
in turn determines the performance of the actual behavior[62-65]. The theory has been used in explaining many
health-related behaviors [35] but not frequently used to
explain decisions on IV [25,66]. Health promotion should
therefore also encourage family members to reinforce par-
ents of young children to take up IV. Future studies
should also compare different types of behavioral health
theories, such as the HBM and TPB in predicting IV in
this and other populations and use such results to plan for
relevant health promotion.
Furthermore, 64.8% of the respondents reported prox-
imity to sites offering IV service as a facilitating condition.
Inconvenience can be seen as another perceived barrier of
the HBM. Almost all private clinics in Hong Kong provide
IV services and currently, the subsidy is close to the mar-
ket rate. Such information should be provided to parents
to inform them about proximal clinics that they may visit
to seek IV services.
It is known that children aged of 6 months to 8 years
who have never been vaccinated previously require two
doses of trivalent influenza vaccine separated in time by >
4 weeks to induce an optimal serum antibody response. A
study assessing protective antibody responses after one and
two doses of vaccine among children aged 5 to 8 years,
who had never received the IV previously, indicated that
children who received two doses were substantially more
likely than those who received one dose to have a protective
antibody response [67]. Another study found that no vac-
cine effectiveness was identified with partial vaccination
among children who were aged 6 to 23 months, affirming
that children need to be fully vaccinated to obtain the pro-
tective effects [68]. In this study, we have a small number of
children who have previously taken up IV (N= 36), but it is
alarming that one-third of them were only partially vacci-
nated. This finding suggests that children of this age group
do not benefit from IV, not only because of the low preva-
lence of IV but furthermore, by the even lower prevalence
of full vaccination with two doses. Therefore, the need for
increased measures to improve the proportion of children
who are fully vaccinated is underscored. We contend that
the knowledge about ineffective partial vaccination is un-
known to the parents because few of them had discussed
with health care professionals about matters related to IV
for their young children.
The study has a few limitations. First, respondents
were recruited from MCHC. Since a large proportion of
the target population visited MCHC, we believe that the
sample has good representativeness. Selection bias could,
however, have been introduced due to convenience sam-
pling although the response rate has been high. Second,
parent-reported IV history has not been validated against
medical records and may be subject to recall bias. How-
ever, other self-reported IV studies have been found to be
valid [69-71]. Self-reported IV among adults, when com-
pared with extraction from the medical record is both a
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http://www.biomedcentral.com/1471-2458/13/1026sensitive and specific source of information [72] and could
rapidly provide available information to guide government
policy and program decisions. Third, items in the present
study were not based on validated scales. However, there
was no standardized scale for HBM and it is very common
that researchers self-constructed the HBM items based on
the studied behavior [73]. Similar self-constructed items
have been used in other studies on IV [69,74]. Finally, fam-
ily members’ experiences with IV were not measured in the
study. Future studies should investigate how such experi-
ences would affect IV among young children. Lastly, the
survey was completed in 2006 and the prevalence may have
changed. The data however, serve as benchmarks for future
comparisons to gauge any improvements have been made.
Conclusions
In conclusion, the prevalence of IV among children aged
6 to 23 months in Hong Kong is very low. The most im-
portant factors related to immunization were doctor rec-
ommendations and parental cognitions related to influenza
and IV based on HBM. To encourage compliance with vac-
cination, multiple strategies should be utilized in the future,
involving parents, doctors and family members. Future
studies should focus on understanding factors predicting
IV, such as longitudinal studies which can establish caus-
ality between factors and IV, and intervention studies (ran-
domized clinical trials) targeting physicians (especially
private doctor) to increase their recommendation to par-
ents, as well as intervention studies targeting parents to in-
crease prevalence of IV for children of 6 to 23 months old.
Similar studies should also be extended to the population
of children aged 24-59 months old as the current WHO
recommendation also covers this older pediatric age group.
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